Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SANOFI-AVENTIS GROUPE

02 6Sanofi Winthrop Industrie

03 2Sanofi-Aventis (Switzerland) Sa

04 3Sanofi-Aventis Looks - Paris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use

Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use

Dosage Strength : 2 cartridges SC in preriemp pen 3 ml 20 mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use

Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg + 1 cartridge SC in preriemp pen 3 ml 20 mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Injection fluid, resolution

Dosage Strength : 10 mcg

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Injection fluid, resolution

Dosage Strength : 20 mcg

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Lixisenatide

Brand Name : Lyxumia Boot Gasket

Dosage Form :

Dosage Strength :

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Injectable Solution

Dosage Strength : 100mg;50mg

Packaging :

Approval Date : 05/10/2017

Application Number : 66283

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Injectable Solution

Dosage Strength : 100mg;33mg

Packaging :

Approval Date : 05/10/2017

Application Number : 66283

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Solution For Injection

Dosage Strength : 100IU/ml;33mcg/ml

Packaging :

Approval Date : 11/01/2017

Application Number : 20160309000010

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Solution For Injection

Dosage Strength : 100IU/ml;50mcg/ml

Packaging :

Approval Date : 11/01/2017

Application Number : 20160309000027

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner